Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
95.8M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
50.2M
-
Shares change
-
+9.7M
-
Total reported value, excl. options
-
$35M
-
Value change
-
+$6.04M
-
Put/Call ratio
-
1.35
-
Number of buys
-
19
-
Number of sells
-
-28
-
Price
-
$0.70
Significant Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q2 2025
76 filings reported holding IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value as of Q2 2025.
IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.2M shares
of 95.8M outstanding shares and own 52.37% of the company stock.
Largest 10 shareholders include Aberdeen Group plc (8.24M shares), BVF INC/IL (7.65M shares), Soleus Capital Management, L.P. (7.29M shares), Avidity Partners Management LP (5.62M shares), VANGUARD GROUP INC (4.13M shares), MORGAN STANLEY (3.63M shares), Focus Partners Wealth (2.54M shares), Laurion Capital Management LP (1.91M shares), Omega Fund Management, LLC (1.79M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1.4M shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.